Suppr超能文献

[地高辛、呋塞米和血管扩张剂治疗慢性充血性心力衰竭时左心室功能的变化]

[Changes in left-ventricular function in chronic congestive heart failure treated with digoxin, furosemide and vasodilators].

作者信息

Markiewicz K, Dryjański T, Cholewa M, Gawor Z

机构信息

I Kliniki Chorób Wewnetrznych Instytutu Medycyny Wewnetrznej WAM w Lodzi.

出版信息

Kardiol Pol. 1990 Feb;33(2):107-15.

PMID:2277481
Abstract

48 patients (62.8 +/- 9.1 yrs) with III or IV NYHa class congestive heart failure after 2-week therapy with digoxin (D) and furosemide (F) underwent two-dimensional echocardiographic examination to assess left ventricular function. Then in 25 patients (group I) DF and nifedipine (N) were given within 2 weeks, D, F, N and captopril (C) within 4 weeks and again D, F, N within 2 weeks. In 23 patients (group II) isosorbide dinitrate (S) was administered instead of nifedipine. 2-DE examination had been performed at the end of the each study stage. Optimal daily drug dose were: D-0.34 +/- 0.07 mg, F-40.7 +/- 12.5 mg, S-44.3 +/- 10.4 mg and 75.8 +/- 26.4 mg. Nifedipine and isosorbide dinitrate administrated with digoxin and furosemide did not improve left ventricular function in comparison with a standard therapy (DF). The best positive changes were observed in both groups during treatment with captopril. Ejection fraction by Teichholz increased from 42.9 +/- 15.0% during DF stage to 45.2 +/- 11.5% (DFNK stage) in group I (p less than 0.001) and from 35.3 +/- 10.5% to 36.4 +/- 10.4% in group II respectively (p greater than 0.01). Left ventricular systolic and diastolic internal diameters significantly decreased (p less than 0.05) whereas stroke volume and cardiac indices nonsignificantly increased (p greater than 0.05). Captopril with digoxine, furosemide and nifedipine caused significant hemodynamic improvement. Effect of captopril with nifedipine was greater that of captopril with isosorbide dinitrate.

摘要

48例(62.8±9.1岁)经地高辛(D)和呋塞米(F)治疗2周后处于纽约心脏协会(NYHA)Ⅲ或Ⅳ级充血性心力衰竭的患者接受了二维超声心动图检查以评估左心室功能。然后,25例患者(Ⅰ组)在2周内给予DF和硝苯地平(N),4周内给予D、F、N和卡托普利(C),随后2周内再次给予D、F、N。23例患者(Ⅱ组)给予硝酸异山梨酯(S)替代硝苯地平。在每个研究阶段结束时均进行了二维超声心动图(2-DE)检查。最佳每日药物剂量为:D-0.34±0.07mg,F-40.7±12.5mg,S-44.3±10.4mg和75.8±26.4mg。与标准治疗(DF)相比,硝苯地平和硝酸异山梨酯与地高辛和呋塞米联合使用并未改善左心室功能。两组在卡托普利治疗期间均观察到最佳的积极变化。Ⅰ组中,Teichholz法测得的射血分数从DF阶段的42.9±15.0%增加至DFNK阶段的45.2±11.5%(p<0.001),Ⅱ组分别从35.3±10.5%增加至36.4±10.4%(p>0.01)。左心室收缩和舒张内径显著减小(p<0.05),而每搏输出量和心脏指数无显著增加(p>0.05)。卡托普利与地高辛、呋塞米和硝苯地平联合使用可导致显著的血流动力学改善。卡托普利与硝苯地平联合使用的效果优于卡托普利与硝酸异山梨酯联合使用的效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验